Leading global pharmaceutical company Allergan has acquired Envy Medical, a privately held company with proprietary technology in skin resurfacing. The addition of Envy’s Dermalinfusion, a non-surgical, non-invasive skin resurfacing system for the face and body offered in physician’s offices, medical spas, and luxury spas, will enhance Allergan’s Medical Aesthetics portfolio. The business also has a complete line of proprietary take-home skincare that will further complement Allergan’s SkinMedica portfolio of skincare products.

“The acquisition of Envy Medical’s Dermalinfusion reinforces our commitment to skin care and to offering a full range of solutions for Allergan customers and consumers. The breakthrough technology for skin resurfacing appeals to millennials and their focus on skin quality and is a perfect opportunity for Allergan to help our healthcare providers capture new patients for this and other medical aesthetic procedures,” Carrie Strom, Senior Vice President, U.S. Medical Aesthetics at Allergan, said in a statement.

Envy Medical CEO Arash Khazei added, “As a leader in non-invasive medical aesthetic devices, we believe the Dermalinfusion system is a perfect fit with Allergan and its product portfolio. We have always looked to broaden awareness and reach of Dermalinfusion, and Allergan’s commitment to innovation, brand development, and global market expansion is perfectly aligned with our vision. We are very excited to join Allergan.”